Glass Jacobson Investment Advisors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-52,800
Closed -$6.34K 880
2025
Q1
$6.34K Hold
52,800
﹤0.01% 649
2024
Q4
$6.34K Hold
52,800
﹤0.01% 649
2024
Q3
$7.25K Buy
52,800
+5,000
+10% +$702 ﹤0.01% 600
2024
Q2
$6.99K Buy
47,800
+5,000
+12% +$749 ﹤0.01% 591
2024
Q1
$6.25K Hold
42,800
﹤0.01% 602
2023
Q4
$8.57K Hold
42,800
﹤0.01% 535
2023
Q3
$7.15K Hold
42,800
﹤0.01% 527
2023
Q2
$8.56K Buy
+42,800
New +$8.68K ﹤0.01% 522
2022
Q4
$6.98K Buy
+42,800
New +$8.77K ﹤0.01% 553

Other funds holding ZOM

Glass Jacobson Investment Advisors's ZOM Position: Q2 2025 in Review

Glass Jacobson Investment Advisors sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 52,800 shares — an estimated $6.34K sold.

Glass Jacobson Investment Advisors first reported a position in ZOM in Q4 2022 and held it in 9 quarters. The position peaked at $8.57K in Q4 2023. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

  • Glass Jacobson Investment Advisors reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 52,800 Zomedica Corp. shares in Q2 2025, an estimated $6.34K.
  • Glass Jacobson Investment Advisors first reported a position in Zomedica Corp. in Q4 2022 and held it in 9 quarters.
  • Glass Jacobson Investment Advisors's Zomedica Corp. position peaked at $8.57K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.